Vertex Pharmaceuticals Inc (VX1.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 08:08AM CEST
| Previous close | 387.25 |
| Open | 389.20 |
| Bid | 392.30 x 0 |
| Ask | 392.65 x 0 |
| Day's range | 389.20 - 389.20 |
| 52-week range | 300.20 - 408.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GuruFocus.comAlpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
Simply Wall St.Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
© 2024 Yahoo. All rights reserved.